Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo Network Comparison Type description Value Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 480 to 529 of 66312 in total
Filtered: 1

\def\wcA{0.1\textwidth}
\def\wcB{0.1\textwidth}
\def\wcC{0.1\textwidth}
\def\wcD{0.1\textwidth}
\def\wcE{0.1\textwidth}
\def\wcF{0.1\textwidth}
\def\wcG{0.1\textwidth}
\def\wcH{0.1\textwidth}
\def\wcI{0.1\textwidth}
\begin{longtable}{|c|c|c|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Value Type\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
30\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRO\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
trophinin. [source:swissprot;acc:q12816]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
219048\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
129762\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
89286\vspace{3pt}}\\\cline{1-2}\cline{4-9}
\multirow{16}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
31\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
atlastin; guanylate-binding protein 3. [source:refseq;acc:nm\_015915]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
142\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
170\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
28\vspace{3pt}}\\\cline{2-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
ARRB2\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
beta-arrestin 2 (arrestin, beta 2). [source:swissprot;acc:p32121]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
9924.76\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
25146.6\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
2.53372\vspace{3pt}}\\\cline{2-2}\cline{4-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
BEST4\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
vitelliform macular dystrophy 2-like protein 2. [source:refseq;acc:nm\_153274]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Measured\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcG}{\vspace{3pt}\noindent
36469.3\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
43503.3\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
1.19287\vspace{3pt}}\\\cline{2-2}\cline{4-5}\cline{7-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
DNASE2B\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
deoxyribonuclease ii beta isoform 1 precursor; deoxyribonuclease ii beta; endonuclease dlad. [source:refseq;acc:nm\_021233]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}}&&\parbox{\wcG}{\vspace{3pt}\noindent
57.395\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
48.8186\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
1.17568\vspace{3pt}}\\\cline{2-4}\cline{6-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
GNAT1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(t), alpha-1 subunit (transducin alpha-1 chain). [source:swissprot;acc:p11488]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcG}{\vspace{3pt}\noindent
267.14\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
336.075\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
68.935\vspace{3pt}}\\\cline{2-5}\cline{7-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
GNG10\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-10 subunit. [source:swissprot;acc:p50151]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Measured\vspace{3pt}}&&\parbox{\wcG}{\vspace{3pt}\noindent
1834.63\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
895.697\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
2.04827\vspace{3pt}}\\\cline{2-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
HINT1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
histidine triad nucleotide-binding protein 1 (adenosine 5'- monophosphoramidase) (protein kinase c inhibitor 1) (protein kinase c- interacting protein 1) (pkci-1). [source:swissprot;acc:p49773]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcG}{\vspace{3pt}\noindent
67.7094\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
56.875\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
10.8344\vspace{3pt}}\\\cline{2-5}\cline{7-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
MAGEA11\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
melanoma-associated antigen 11 (mage-11 antigen). [source:swissprot;acc:p43364]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&&\parbox{\wcG}{\vspace{3pt}\noindent
82347.8\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
61881.5\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
1.33073\vspace{3pt}}\\\cline{2-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
MAGEB6B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
melanoma antigen, family b, 6. [source:refseq;acc:nm\_173523]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Measured\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
18263\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
5430.7\vspace{3pt}}\\\cline{2-9}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
MRPS17\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
28s ribosomal protein s17, mitochondrial precursor (mrp-s17) (hspc011). [source:swissprot;acc:q9y2r5]\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
145.551\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
168.796\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
1.1597\vspace{3pt}}\\\cline{3-3}\cline{5-9}
&&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcG}{\vspace{3pt}\noindent
106226\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
192141\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
85915\vspace{3pt}}\\\cline{2-5}\cline{7-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
PPP1R14D\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory subunit 14d; pkc-dependent pp1 inhibitory protein. [source:refseq;acc:nm\_017726]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}&&\parbox{\wcG}{\vspace{3pt}\noindent
26.0288\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
43.1914\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
1.65937\vspace{3pt}}\\\cline{2-2}\cline{4-5}\cline{7-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
PPP2R2B\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 55 kda regulatory subunit b, beta isoform (pp2a, subunit b, b-beta isoform) (pp2a, subunit b, b55- beta isoform) (pp2a, subunit b, pr55-beta isoform) (pp2a, subunit b, r2-beta isoform). [source:swissprot;acc:q00005]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}&&\parbox{\wcG}{\vspace{3pt}\noindent
187.458\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
243.677\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
1.2999\vspace{3pt}}\\\cline{2-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
PSCD3\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
cytohesin 3 (arf nucleotide-binding site opener 3) (arno3 protein) (general receptor of phosphoinositides 1) (grp1). [source:swissprot;acc:o43739]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcG}{\vspace{3pt}\noindent
92920.4\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
71796.4\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
21124\vspace{3pt}}\\\cline{2-2}\cline{4-5}\cline{7-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
TUSC3\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
n33 protein. [source:swissprot;acc:q13454]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Measured\vspace{3pt}}&&\parbox{\wcG}{\vspace{3pt}\noindent
3278\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5058.5\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
1780.5\vspace{3pt}}\\\cline{2-2}\cline{4-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
UFC1\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
protein cgi-126 (protein hspc155). [source:swissprot;acc:q9y3c8]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcG}{\vspace{3pt}\noindent
40.0958\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
58.7986\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
18.7028\vspace{3pt}}\\\cline{1-5}\cline{7-9}
\multirow{16}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
32\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-5 like subunit. [source:swissprot;acc:q9y3k8]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Measured\vspace{3pt}}}&&\parbox{\wcG}{\vspace{3pt}\noindent
1834.73\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
895.893\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
2.04793\vspace{3pt}}\\\cline{4-4}\cline{6-9}
&&&\parbox{\wcD}{\vspace{3pt}\noindent
nuclear dna-binding protein; small unique nuclear receptor corepressor; c1d dna-binding protein. [source:refseq;acc:nm\_006333]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcG}{\vspace{3pt}\noindent
36360.3\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
43368.8\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
1.19275\vspace{3pt}}\\\cline{3-4}\cline{7-9}
&&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
implantation-associated protein. [source:refseq;acc:nm\_032121]\vspace{3pt}}&&&\parbox{\wcG}{\vspace{3pt}\noindent
3278\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5058.5\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
1780.5\vspace{3pt}}\\\cline{4-4}\cline{6-9}
&&&\parbox{\wcD}{\vspace{3pt}\noindent
melanoma-associated antigen 4 (mage-4 antigen) (mage-x2) (mage-41). [source:swissprot;acc:p43358]\vspace{3pt}}&&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcG}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
18263\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
5430.7\vspace{3pt}}\\\cline{2-5}\cline{7-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
ARRB1\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
beta-arrestin 1 (arrestin, beta 1). [source:swissprot;acc:p49407]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&&\parbox{\wcG}{\vspace{3pt}\noindent
9924.76\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
25146.6\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
2.53372\vspace{3pt}}\\\cline{2-2}\cline{4-5}\cline{7-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
FCN2\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
ficolin 2 precursor (collagen/fibrinogen domain-containing protein 2) (ficolin-b) (ficolin b) (serum lectin p35) (ebp-37) (hucolin) (l- ficolin). [source:swissprot;acc:q15485]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}&&\parbox{\wcG}{\vspace{3pt}\noindent
26.0288\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
43.1914\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
1.65937\vspace{3pt}}\\\cline{2-5}\cline{7-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
GNAI2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i), alpha-2 subunit (adenylate cyclase-inhibiting g alpha protein). [source:swissprot;acc:p04899]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}&&\parbox{\wcG}{\vspace{3pt}\noindent
267.142\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
336.074\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
68.932\vspace{3pt}}\\\cline{2-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
MAGEA2B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
melanoma-associated antigen 2 (mage-2 antigen). [source:swissprot;acc:p43356]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Squared\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
82347.8\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
61881.5\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
1.33073\vspace{3pt}}\\\cline{2-4}\cline{6-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
PANK1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
pantothenate kinase 1 (ec 2.7.1.33) (pantothenic acid kinase 1) (hpank1) (hpank). [source:swissprot;acc:q8te04]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcG}{\vspace{3pt}\noindent
106226\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
192141\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
85915\vspace{3pt}}\\\cline{2-5}\cline{7-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
PPP2R2C\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 55 kda regulatory subunit b, gamma isoform (pp2a, subunit b, b-gamma isoform) (pp2a, subunit b, b55-gamma isoform) (pp2a, subunit b, pr55-gamma isoform) (pp2a, subunit b, r2-gamma isoform) (imypno1). [source:swissprot;acc:q9y2t4]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}}&&\parbox{\wcG}{\vspace{3pt}\noindent
187.462\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
243.673\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
1.29985\vspace{3pt}}\\\cline{2-2}\cline{4-4}\cline{6-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
PRKRAP1\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
protein kinase, interferon-inducible double stranded rna dependent activator; protein activator of the interferon-induced protein kinase. [source:refseq;acc:nm\_003690]\vspace{3pt}}&&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcG}{\vspace{3pt}\noindent
273.188\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
232.49\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
1.17505\vspace{3pt}}\\\cline{2-5}\cline{7-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
PSCD4\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
cytohesin 4. [source:swissprot;acc:q9uia0]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&&\parbox{\wcG}{\vspace{3pt}\noindent
92262.9\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
71400.2\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
20862.7\vspace{3pt}}\\\cline{2-2}\cline{4-5}\cline{7-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
RGS12\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
regulator of g-protein signaling 12 (rgs12). [source:swissprot;acc:o14924]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}&&\parbox{\wcG}{\vspace{3pt}\noindent
247.768\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
219.841\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
27.927\vspace{3pt}}\\\cline{2-5}\cline{7-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
SLC25A43\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
mitochondrial solute carrier protein. [source:refseq;acc:nm\_145305]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}}&&\parbox{\wcG}{\vspace{3pt}\noindent
145.551\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
168.796\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
1.1597\vspace{3pt}}\\\cline{2-4}\cline{6-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
TMEM132A\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
gbp protein isoform a. [source:refseq;acc:nm\_017870]\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
23.9771\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
42.4773\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
18.5002\vspace{3pt}}\\\cline{2-2}\cline{4-4}\cline{6-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
TOB2\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
tob2 protein (transducer of erbb-2 2). [source:swissprot;acc:q14106]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcG}{\vspace{3pt}\noindent
38.4152\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
49.1529\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
10.7377\vspace{3pt}}\\\cline{1-5}\cline{7-9}
\multirow{16}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
33\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
hepatocellular carcinoma-associated protein hca1. [source:refseq;acc:nm\_020932]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&&\parbox{\wcG}{\vspace{3pt}\noindent
82347.8\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
61881.5\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
1.33073\vspace{3pt}}\\\cline{4-9}
&&&\parbox{\wcD}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14c; serologically defined breast cancer antigen ny-br-81; pkc-potentiated pp1 inhibitory protein. [source:refseq;acc:nm\_030949]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
26.0288\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
43.1914\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
1.65937\vspace{3pt}}\\\cline{2-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
ATG4B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
cysteine endopeptidase aut-like isoform b. [source:refseq;acc:nm\_178326]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcG}{\vspace{3pt}\noindent
77316.3\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
56522.1\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
20794.2\vspace{3pt}}\\\cline{2-5}\cline{7-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
BEST2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
vitelliform macular dystrophy 2-like protein 1. [source:refseq;acc:nm\_017682]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Measured\vspace{3pt}}&&\parbox{\wcG}{\vspace{3pt}\noindent
36360.3\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
43368.8\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
1.19275\vspace{3pt}}\\\cline{2-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
GNAI1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i), alpha-1 subunit (adenylate cyclase-inhibiting g alpha protein). [source:swissprot;acc:p04898]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcG}{\vspace{3pt}\noindent
267.144\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
336.073\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
68.929\vspace{3pt}}\\\cline{2-5}\cline{7-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
GNG11\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-11 subunit. [source:swissprot;acc:p50152]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Measured\vspace{3pt}}&&\parbox{\wcG}{\vspace{3pt}\noindent
1835.3\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
896.972\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
2.04611\vspace{3pt}}\\\cline{2-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
GSTO2\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
ba127l20.1 (novel glutathione-s-transferase). [source:sptrembl;acc:q9h4y5]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
228.147\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
200.55\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
27.597\vspace{3pt}}\\\cline{2-2}\cline{4-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
MAGEA9\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
melanoma-associated antigen 9 (mage-9 antigen). [source:swissprot;acc:p43362]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Measured\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
18263\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
5430.7\vspace{3pt}}\\\cline{2-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
MAP2K4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
dual specificity mitogen-activated protein kinase kinase 4 (ec 2.7.1.-) (map kinase kinase 4) (jnk activating kinase 1) (c-jun n- terminal kinase kinase 1) (jnkk) (sapk/erk kinase 1) (sek1). [source:swissprot;acc:p45985]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
210.241\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
246.125\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
1.17068\vspace{3pt}}\\\cline{2-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
PANK2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
pantothenate kinase 2, mitochondrial precursor (ec 2.7.1.33) (pantothenic acid kinase 2) (hpank2). [source:swissprot;acc:q9bz23]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcG}{\vspace{3pt}\noindent
106226\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
192141\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
85915\vspace{3pt}}\\\cline{2-5}\cline{7-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
PPP2R1B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 65 kda regulatory subunit a, beta isoform (pp2a, subunit a, pr65-beta isoform) (pp2a, subunit a, r1-beta isoform). [source:swissprot;acc:p30154]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}&&\parbox{\wcG}{\vspace{3pt}\noindent
188.688\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
242.742\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
1.28647\vspace{3pt}}\\\cline{2-5}\cline{7-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
PRKRAP1\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
protein kinase, interferon-inducible double stranded rna dependent activator; protein activator of the interferon-induced protein kinase. [source:refseq;acc:nm\_003690]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}&&\parbox{\wcG}{\vspace{3pt}\noindent
25.6987\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
43.561\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
17.8623\vspace{3pt}}\\\cline{2-2}\cline{4-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
SEPT6\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
septin 6. [source:swissprot;acc:q14141]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Measured\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
13005.8\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
14773.7\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
1767.9\vspace{3pt}}\\\cline{2-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
SPATA6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
spermatogenesis associated 6. [source:refseq;acc:nm\_019073]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
9924.76\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
25146.6\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
2.53372\vspace{3pt}}\\\cline{2-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
TOB1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
tob1 protein (transducer of erbb-2 1). [source:swissprot;acc:p50616]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcG}{\vspace{3pt}\noindent
38.5678\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
49.2633\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
10.6955\vspace{3pt}}\\\cline{2-4}\cline{7-9}
&\parbox{\wcB}{\vspace{3pt}\noindent
UBR4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
retinoblastoma-associated factor 600. [source:refseq;acc:nm\_020765]\vspace{3pt}}&&&\parbox{\wcG}{\vspace{3pt}\noindent
76.5734\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
88.6244\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
1.15738\vspace{3pt}}\\\cline{1-4}\cline{6-9}
\parbox{\wcA}{\vspace{3pt}\noindent
34\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
gaba-a receptor-associated protein. [source:sptrembl;acc:q9by60]\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
140.508\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
122.878\vspace{3pt}}&\parbox{\wcI}{\vspace{3pt}\noindent
17.63\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/